PROSIEBENSAT1 MED. NPV (OTCMKTS:PBSFF)‘s stock had its “neutral” rating reissued by analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Friday.
Separately, DZ Bank AG reaffirmed a “sell” rating on shares of PROSIEBENSAT1 MED. NPV in a research report on Friday, August 5th.
Shares of PROSIEBENSAT1 MED. NPV (OTCMKTS:PBSFF) opened at 41.16 on Friday. The firm has a 50-day moving average price of $44.12 and a 200-day moving average price of $46.74. The firm has a market cap of $8.83 billion and a P/E ratio of 21.64. PROSIEBENSAT1 MED. NPV has a 12-month low of $39.66 and a 12-month high of $53.96.
Receive News & Ratings for PROSIEBENSAT1 MED. NPV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PROSIEBENSAT1 MED. NPV and related companies with MarketBeat.com's FREE daily email newsletter.